{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:47:39Z","timestamp":1760852859922,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3881,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1006\/viro.2002.1659","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T07:20:15Z","timestamp":1041060015000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of 1,8-Diaminooctane on the FIV Rev Regulatory System"],"prefix":"10.1006","volume":"304","author":[{"given":"Richard A.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-No\u00ebl","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/viro.2002.1659_RF1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0006-2952(98)00053-7","article-title":"Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: A hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)","volume":"55","author":"Andrus","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/viro.2002.1659_RF2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000109118","article-title":"Eukaryotic initiation factor 5A activity and HIV-1 Rev function","volume":"6","author":"Bevec","year":"1997","journal-title":"Biol. Signals"},{"key":"10.1006\/viro.2002.1659_RF3","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1126\/science.271.5257.1858","article-title":"Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A","volume":"271","author":"Bevec","year":"1996","journal-title":"Science"},{"key":"10.1006\/viro.2002.1659_RF4","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1073\/pnas.91.23.10829","article-title":"Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes","volume":"91","author":"Bevec","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2002.1659_RF5","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1128\/JVI.72.11.8627-8635.1998","article-title":"Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1","volume":"72","author":"Bogerd","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.2002.1659_RF6","first-page":"481","article-title":"Polyamines and their derivatives as modulators in growth and differentiation","volume":"62","author":"Canellakis","year":"1989","journal-title":"Yale J. Biol. Med."},{"key":"10.1006\/viro.2002.1659_RF7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy [see comments]","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1006\/viro.2002.1659_RF8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/342816a0","article-title":"Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro","volume":"342","author":"Daly","year":"1989","journal-title":"Nature"},{"key":"10.1006\/viro.2002.1659_RF9","doi-asserted-by":"crossref","first-page":"16585","DOI":"10.1016\/S0021-9258(18)49296-4","article-title":"Eukaryotic initiation factor 4D, the hypusine-containing protein, is conserved among eukaryotes","volume":"262","author":"Gordon","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0167-4889(94)90003-5","article-title":"Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation","volume":"1221","author":"Hanauske-Abel","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/viro.2002.1659_RF11","first-page":"55","article-title":"Nuclear export mediated by the Rev\/Rex class of retroviral Trans-activator proteins","volume":"259","author":"Hauber","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1006\/viro.2002.1659_RF12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [see comments]","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"10.1006\/viro.2002.1659_RF13","doi-asserted-by":"crossref","first-page":"13151","DOI":"10.1016\/S0021-9258(19)38631-4","article-title":"Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines","volume":"268","author":"Jakus","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF14","doi-asserted-by":"crossref","first-page":"25916","DOI":"10.1016\/S0021-9258(18)47333-4","article-title":"Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine","volume":"269","author":"Joe","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF15","doi-asserted-by":"crossref","first-page":"32679","DOI":"10.1074\/jbc.272.51.32679","article-title":"Enzyme-substrate intermediate at a specific lysine residue is required for deoxyhypusine synthesis. The role of Lys329 in human deoxyhypusine synthase","volume":"272","author":"Joe","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF16","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1089\/hum.1996.7.15-1861","article-title":"Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: A feasibility study","volume":"7","author":"Junker","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/viro.2002.1659_RF17","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/jvi.69.5.3125-3133.1995","article-title":"Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding","volume":"69","author":"Katahira","year":"1995","journal-title":"J. Virol."},{"key":"10.1006\/viro.2002.1659_RF18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0968-0896(97)10030-X","article-title":"Branched-chain and unsaturated 1,7-diaminoheptane derivatives as deoxyhypusine synthase inhibitors","volume":"6","author":"Lee","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1006\/viro.2002.1659_RF19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0969-2126(98)00004-5","article-title":"Crystal structure of the NAD complex of human deoxyhypusine synthase: An enzyme with a ball-and-chain mechanism for blocking the active site","volume":"6","author":"Liao","year":"1998","journal-title":"Structure"},{"key":"10.1006\/viro.2002.1659_RF20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000109123","article-title":"Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification","volume":"6","author":"Liu","year":"1997","journal-title":"Biol. Signals"},{"key":"10.1006\/viro.2002.1659_RF21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/335181a0","article-title":"Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes","volume":"335","author":"Malim","year":"1988","journal-title":"Nature"},{"key":"10.1006\/viro.2002.1659_RF22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(90)90670-A","article-title":"HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence","volume":"60","author":"Malim","year":"1990","journal-title":"Cell"},{"key":"10.1006\/viro.2002.1659_RF23","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/jvi.68.3.1998-2001.1994","article-title":"Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus","volume":"68","author":"Mancuso","year":"1994","journal-title":"J. Virol."},{"key":"10.1006\/viro.2002.1659_RF24","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1016\/S0021-9258(17)43083-3","article-title":"The mammalian hypusine-containing protein, eukaryotic initiation factor 4D. Structural homology of this protein from several species","volume":"259","author":"Park","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF25","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1074\/jbc.273.3.1677","article-title":"Deoxyhypusine synthase activity is essential for cell viability in the yeast Saccharomyces cerevisiae","volume":"273","author":"Park","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000109117","article-title":"Hypusine is essential for eukaryotic cell proliferation","volume":"6","author":"Park","year":"1997","journal-title":"Biol. Signals"},{"key":"10.1006\/viro.2002.1659_RF27","first-page":"95","article-title":"Hypusine: Its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation","volume":"4","author":"Park","year":"1993","journal-title":"Biofactors"},{"key":"10.1006\/viro.2002.1659_RF28","doi-asserted-by":"crossref","first-page":"27827","DOI":"10.1016\/S0021-9258(18)46861-5","article-title":"Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines","volume":"269","author":"Park","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.3643650","article-title":"Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome","volume":"235","author":"Pedersen","year":"1987","journal-title":"Science"},{"key":"10.1006\/viro.2002.1659_RF30","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1128\/jvi.66.9.5464-5471.1992","article-title":"Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus","volume":"66","author":"Phillips","year":"1992","journal-title":"J. Virol."},{"key":"10.1006\/viro.2002.1659_RF31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1099\/0022-1317-75-5-979","article-title":"Neurological abnormalities associated with feline immunodeficiency virus infection","volume":"75","author":"Phillips","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.2002.1659_RF32","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/jvi.64.10.4605-4613.1990","article-title":"Comparison of two host cell range variants of feline immunodeficiency virus","volume":"64","author":"Phillips","year":"1990","journal-title":"J. Virol."},{"key":"10.1006\/viro.2002.1659_RF33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.micro.52.1.491","article-title":"The HIV-1 Rev protein","volume":"52","author":"Pollard","year":"1998","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1006\/viro.2002.1659_RF34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1083\/jcb.123.6.1309","article-title":"Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation","volume":"123","author":"Ruhl","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1006\/viro.2002.1659_RF35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.95.4.1607","article-title":"Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5","volume":"95","author":"Schatz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2002.1659_RF36","doi-asserted-by":"crossref","first-page":"18527","DOI":"10.1016\/S0021-9258(18)51499-X","article-title":"Protein synthesis initiation factor eIF-4D. Functional comparison of native and unhypusinated forms of the protein","volume":"264","author":"Smit","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0888-7543(95)80025-H","article-title":"The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12\u2013p13: Three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2","volume":"25","author":"Steinkasserer","year":"1995","journal-title":"Genomics"},{"key":"10.1006\/viro.2002.1659_RF38","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1073\/pnas.86.15.5743","article-title":"Nucleotide sequence and genomic organization of feline immunodeficiency virus","volume":"86","author":"Talbott","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2002.1659_RF39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1074\/jbc.270.1.383","article-title":"Purification of deoxyhypusine synthase from Neurospora crassa to homogeneity by substrate elution affinity chromatography","volume":"270","author":"Tao","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.2002.1659_RF40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/abio.1994.1385","article-title":"Deoxyhypusine synthase assay based on the use of polyhistidine-tagged substrate and metal chelate-affinity chromatography","volume":"221","author":"Tao","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1006\/viro.2002.1659_RF41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0014-4827(84)90169-1","article-title":"Cellular proliferation and hypusine synthesis","volume":"154","author":"Torrelio","year":"1984","journal-title":"Exp. Cell Res."},{"key":"10.1006\/viro.2002.1659_RF42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection [see comments]","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"10.1006\/viro.2002.1659_RF43","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.1074\/jbc.270.15.8660","article-title":"Deoxyhypusine synthase from rat testis: Purification and characterization","volume":"270","author":"Wolff","year":"1995","journal-title":"J. Biol. Chem."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682202916594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682202916594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:18:55Z","timestamp":1758583135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682202916594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0042682202916594"],"URL":"https:\/\/doi.org\/10.1006\/viro.2002.1659","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of 1,8-Diaminooctane on the FIV Rev Regulatory System","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.2002.1659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science (USA). All rights reserved.","name":"copyright","label":"Copyright"}]}}